Maternal, fetal and neonatal outcomes of pregnant women with COVID-19 referred to Semnan hospitals; a historical cohort study

How to Cite:Satinik DarziSahereh ArabianMajid Mirmohammadkhanihanif jamshidiMaternal, fetal and neonatal outcomes of pregnant women with COVID-19 referred to Semnan hospitals; a historical cohort study.koomesh.2025;27(1):e153711.https://doi.org/10.69107/koomesh-153711.

Abstract

Introduction: Considering the risks of infectious diseases, especially COVID-19 in pregnant women and the existence of ambiguous results related to this disease on the health of mothers and babies, this study aims to determine the maternal, fetal, and neonatal consequences of COVID-19 in pregnant women. Methods: In this retrospective cohort study, 233 pregnant women (113 infected and 120 not infected with COVID-19) ≥ 18 years of age were referred to Kausar and Amirul Mominin (AS) hospitals in Semnan from April 2018 until May 2023. They were selected by the convenience method. Inclusion criteria included: age ≥ 18 years and access to clinical records. Women with chronic diseases, diabetes and gestational hypertension, eclampsia and pre-eclampsia, other infectious diseases, and people with disorders in pregnancy screening tests were excluded from the study. Demographic information and maternal, fetal, and neonatal outcomes of the two groups were compared using clinical records and phone calls. Results: In women with COVID-19 compared to non-infected, the prevalence of hospitalization in the intensive care unit (P = 0.003), premature rupture of the amniotic sac (P = 0.039), gestational diabetes (P = 0.003), pregnancy hypertension (P = 0.016), preterm labour (P = 0.006), cesarean section (P < 0.001), intrauterine fetal growth restriction (P = 0.032), abortion (P = 0.038), fetal death (P = 0.042) and hospitalization of the newborn in the intensive care unit (P = 0.006) were significantly higher. Apgar score of one minute (8.34 ± 1.54 vs. 8.65 ± 0.87 and P = 0.048) and five minutes (9.61 ± 1.12 vs. 9.74 ± 0.68 and P = 0.039) in the neonates of affected women were less than the other group. Conclusion: Health policies based on the education of the symptoms and risks of the disease, as well as screening and faster identification of pregnant women with COVID-19 at higher risk and providing appropriate facilities to control their risk factors and planning to make effective decisions in prevention and clinical management with quick diagnosis and timely treatment in the early stages, is necessary, which is recommended.

Keywords

COVID-19

Pregnancy Complications

Pregnancy Outcome

References

1.
Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE. The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. 2021;476(11):4161-6. [PubMed ID:34319496]. [PubMed Central ID:PMC8317144]. https://doi.org/10.1007/s11010-021-04232-z.
2.
Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE. Niclosamide for Covid-19: bridging the gap. Mol Biol Rep. 2021;48(12):8195-202. [PubMed ID:34664162]. [PubMed Central ID:PMC8522539]. https://doi.org/10.1007/s11033-021-06770-7.
3.
Al-Kuraishy HM, Al-Gareeb AI. From SARS-CoV to nCoV-2019: Ruction and Argument. Arch Clin Infect Dis. 2020;15(COVID-19). https://doi.org/10.5812/archcid.102624.
4.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical Manifestations, Risk Factors, and Maternal and Perinatal Outcomes of Coronavirus Disease 2019 in Pregnancy: Living Systematic Review and Meta-analysis. Obstetric Anesth Digest. 2021;41(2):81-2. https://doi.org/10.1097/01.aoa.0000744128.44930.48.
5.
Della Gatta AN, Rizzo R, Pilu G, Simonazzi G. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol. 2020;223(1):36-41. [PubMed ID:32311350]. [PubMed Central ID:PMC7165087]. https://doi.org/10.1016/j.ajog.2020.04.013.
6.
Banaei M, Ghasemi V, Saei Ghare Naz M, Kiani Z, Rashidi-Fakari F, Banaei S, et al. Obstetrics and Neonatal Outcomes in Pregnant Women with COVID-19: A Systematic Review. Iran J Public Health. 2020;49(Suppl 1):38-47. [PubMed ID:34268204]. [PubMed Central ID:PMC8266025]. https://doi.org/10.18502/ijph.v49iS1.3668.
7.
Al-kuraishy HM, Al-Niemi MS, Al-Gareeb AI, Al-Harchan NA, Al-Kurashi AH. The Potential Role of Renin Angiotensin System (RAS) and Dipeptidyl Peptidase-4 (DPP-4) in COVID-19: Navigating the Uncharted. In: Kibel A, editor. Selected Chapters from the Renin-Angiotensin System. Rijeka: IntechOpen; 2020.
8.
Onohuean H, Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Batiha GE. Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(10):2013-21. [PubMed ID:34480616]. [PubMed Central ID:PMC8417660]. https://doi.org/10.1007/s00210-021-02147-6.
9.
Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020;55(5):700-8. [PubMed ID:32160345]. [PubMed Central ID:PMC7228229]. https://doi.org/10.1002/uog.22013.
10.
Al-Kuraishy H, Hussien N, Al-Naimi M, Al-Buhadily A, Al-Gareeb A, Lungnier C. Is ivermectin–Azithromycin combination the next step for COVID-19? Biomed Biotechnol Res J (BBRJ). 2020;4(5). https://doi.org/10.4103/bbrj.bbrj_109_20.
11.
Zhang L, Jiang Y, Wei M, Cheng BH, Zhou XC, Li J, et al. [Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province]. Zhonghua Fu Chan Ke Za Zhi. 2020;55(3):166-71. Chinese. [PubMed ID:32145714]. https://doi.org/10.3760/cma.j.cn112141-20200218-00111.
12.
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823-9. [PubMed ID:32259279]. [PubMed Central ID:PMC7262097]. https://doi.org/10.1111/aogs.13867.
13.
Schwartz DA. The Effects of Pregnancy on Women With COVID-19: Maternal and Infant Outcomes. Clin Infect Dis. 2020;71(16):2042-4. [PubMed ID:32392330]. [PubMed Central ID:PMC7239237]. https://doi.org/10.1093/cid/ciaa559.
14.
Askary E, Poordast T, Shiravani Z, Ali MA, Hashemi A, Naseri R, et al. Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series. Int J Reprod Biomed. 2021;19(2):191-204. [PubMed ID:33718763]. [PubMed Central ID:PMC7922300]. https://doi.org/10.18502/ijrm.v19i2.8477.
15.
Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. Canadian Med Assoc J. 2021;193(16):E540-E8. [PubMed ID:33741725]. [PubMed Central ID:PMC8084555]. https://doi.org/10.1503/cmaj.202604.
16.
Li N, Han L, Peng M, Lv Y, Ouyang Y, Liu K, et al. Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study. Clin Infect Dis. 2020;71(16):2035-41. [PubMed ID:32249918]. [PubMed Central ID:PMC7184430]. https://doi.org/10.1093/cid/ciaa352.
17.
Bashyam AM, Feldman SR. Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatolog Treat. 2020;31(4):317-8. [PubMed ID:32191143]. https://doi.org/10.1080/09546634.2020.1742438.
18.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. [PubMed ID:33782057]. [PubMed Central ID:PMC8005924]. https://doi.org/10.1136/bmj.n71.
19.
Barbero P, Muguerza L, Herraiz I, Garcia Burguillo A, San Juan R, Forcen L, et al. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19. J Matern Fetal Neonatal Med. 2022;35(14):2648-54. [PubMed ID:32689846]. https://doi.org/10.1080/14767058.2020.1793320.
20.
Porsoleiman L, Sadeghi M. [A Survey on the Effect, of Covid19 on Pregnant Women and its Complications on their Fetuses and Newborn Childs (from February 2020 to January 2021)]. Paramedical Sci Military Health. 2020;15(3):65-72. Persian.
21.
Marinelli KA, Lawrence RM. Response to Letters to the Editor about the Safe Handling of Containers of Expressed Human Milk in all Settings During the SARS-CoV-2 (COVID-19) Pandemic. J Hum Lact. 2020;36(3):543-7. [PubMed ID:32324443]. https://doi.org/10.1177/0890334420924351.
22.
Moaya M, Shahali S, Farhoudi B. [Maternal and neonatal outcomes of pregnant women with COVID-19 in Amir-al-momenin hospital during March to may 2020]. Iran J Obstetrics, Gynecol Infertility. 2022;23(9):35-42. Persian.

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Satinik Darzi:[PubMed][Scholar]
Sahereh Arabian:[PubMed][Scholar]
Majid Mirmohammadkhani:[PubMed][Scholar]
hanif jamshidi:[PubMed][Scholar]